Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
BMC Plant Biol 16:87
[35] Orforglipron Orforglipron is an oral non-peptide small-molecule GLP-1 receptor agonist approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity, in combination with reduced-calorie diet and increased physical activity
These changes may lead to a satiety hormone imbalance and signal impairments in the hypothalamus, which are involved in satiety (133)
What's the dose in trials
US$ 29.38
US$ 20.26
US$ 22.95
US$ 23.51
